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Abstract
Background: Klebsiella pneumoniae liver abscess (KPLA) has been reported with increasing frequency in East Asian
countries in the past 3 decades, especially in Taiwan and Korea. Diabetes is a well-known risk factor for KPLA and
highly associated with septic metastatic complications from KPLA. We investigated the association of glycemic
control in diabetic patients with the clinical characteristics of KPLA in Taiwan.
Methods: Adult diabetic patients with KPLA were identified retrospectively in a medical center from January 2007
to January 2012. Clinical characteristics were compared among patients with different levels of current hemoglobin
A1c (HbA1c). Risk factors for metastatic infection from KPLA were analyzed.
Results: Patients with uncontrolled glycemia (HbA1c ≥ 7%) were significantly younger than those with controlled
glycemia (HbA1c < 7%). Patients with uncontrolled glycemia had the trend to have a higher rate of gas-forming
liver abscess, cryptogenic liver abscess, and metastatic infection than those with controlled glycemia. Cryptogenic
liver abscess and metastatic infection were more common in the poor glycemic control group (HbA1c value > 10%)
after adjustment with age. HbA1c level and abscess < 5 cm were independent risk factors for metastatic
complications from KPLA.
Conclusions: Glycemic control in diabetic patients played an essential role in the clinical characteristics of KPLA,
especially in metastatic complications from KPLA.
Background
Klebsiella pneumoniae liver abscess (KPLA) has been re-
ported with increasing frequency in East Asian countries
in the past 3 decades, especially in Taiwan and Korea
[1-7]. K. pneumoniae is the dominant cause of pyogenic
liver abscesses in Taiwan and has contributed to the en-
demic feature of the disease in Taiwan [8-10]. Since
1986, many researchers in Taiwan and several other
areas have noted the distinctive syndrome of KPLA,
complicated by bacteremia, sepsis, and metastatic infec-
tion of brain, eyes, lungs and other organs, especially in
patients with diabetes [2,5,6,11-15]. The mortality rate of
KPLA has decreased in recent years in Taiwan [6,8]; ne-
vertheless, despite aggressive therapy, the outcomes of
these patients frequently involve catastrophic disability.
Our recent study also has indicated that catastrophic
disability due to ocular or neurological complications
from KPLA could lead to poor long-term prognosis [10].
Patients with diabetes are at increased risk for com-
mon infection due to impaired host defense mechanisms
[16]. Diabetes is a well-known risk factor for pyoge-
nic liver abscess [17] and highly associated with KPLA
[5,18,19]. One animal study of KPLA has suggested that
diabetes might provide a specialized environment that
allows K. pneumoniae strains to disseminate from the in-
testines into the blood [20]. In addition, diabetes is the
most common underlying disease among patients with
septic metastatic complications from KPLA [12,13,19,21],
and predisposes patients with KPLA to develop septic me-
tastasis [22]. Compared with the monomicrobial crypto-
genic noninvasive KPLA, cryptogenic KPLA with septic
metastasis is characterized by an ~20-fold increased asso-
ciation with diabetes [23].
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Previous studies have compared the characteristics of
liver abscess patients with and without diabetes [17,18,24].
The influence of diabetes on KPLA has also been des-
cribed [1]. However, no research is available on the impact
of glycemic control on the characteristics of KPLA in dia-
betic patients. To monitor glycemic control, hemoglobin
A1c (HbA1c) gives an estimate of average blood glucose
during the preceding 3 months, and is widely accepted as
the primary indicator of the level of glycemic control for
optimal management of diabetes [25].
Therefore, we conducted this study to investigate whe-
ther glycemic control assessed by HbA1c affected the clin-
ical characteristics of diabetic patients with KPLA.
Methods
Study design, patient populations, and data collection
This study was a retrospective cohort analysis of con-
secutive diabetic patients with KPLA at Taipei Veterans
General Hospital, a tertiary medical center with a 2900-
bed capacity. Those patients with KPLA were identified
by reviewing culture records from the Department of
Microbiology from January 2007 to January 2012. We ex-
cluded patients aged < 20 years. Age, sex, underlying dis-
eases, clinical presentations, laboratory findings, including
images, and management were collected. Assessment of
blood glucose control was based on HbA1c levels at the
time of infection or as close to the time of infection as
possible, within one month before this episode of KPLA.
The major outcome measurements included intensive
care unit admission within 48 hours, length of hospi-
talization, and mortality. Septic metastatic infection is
highly associated with diabetic patients with KPLA; there-
fore, we analyzed the risk factors among these patients.
This study was approved by Institutional Review Board of
Taipei Veterans General Hospital.
Definitions
An episode of KPLA was defined as the presence of ≥ 1
liver abscess, detected by sonography or computed tom-
ography, and culture-confirmed K. pneumoniae isola-
ted from an abscess or blood. Only the first episode of
KPLA in a particular patient, diagnosed at our hospital
during the period of study, was included. For the diag-
nosis of diabetes, the American Diabetes Association
diagnostic criteria were used [25]. Patients with diabetes
were defined as those with a history of either type 1 or
type 2 diabetes and/or those taking either insulin and/or
oral hypoglycemic agents. If diabetes was diagnosed dur-
ing the patient’s treatment for this episode of KPLA,
newly diagnosed diabetes was recorded. Chronic kidney
disease was indicated by a creatinine level ≥ 2.0 mg/dL.
Chronic lung disease was defined as chronic obstructive
pulmonary diseases, bronchiectasis, or any structural lung
diseases with the exception of bronchogenic carcinoma.
Cryptogenic origin of infection was defined as that in
which no obvious extrahepatic source of infection could
be identified [22]; biliary tract origin was defined if clinical
features of cholecystitis/cholangitis or extrahepatic biliary
ductal abnormalities were identified on radiographic ima-
ges. Multiple abscesses mean > 2 abscess in liver paren-
chyma confirmed by imaging. Metastatic infection was
defined as a distant site of infection isolated with the same
pathogen as the pyogenic liver abscess (K. pneumoniae).
Microbiology laboratory procedures
The VITEK 2 system (bioMérieux, Marcy l'Etoile, France)
was used to confirm bacterial identifications among the
available isolates. magA is the serotype K1 wzy allele and
was determined among the K. pneumonaie isolates as
described previously [6].
Statistical analysis
We performed a 2-tailed χ2 test or Fisher’s exact test
(for contingency data) and Student’s t test or ANOVA
method (for continuous data) to compare the groups
with different HbA1c levels. A P value < 0.05 was con-
sidered statistically significant; all probabilities were
2-tailed. Cochran-Mantel-Haenszel test with median age
as the stratum was used to analyze the association be-
tween glycemic control and other factors. To identify
possible independent predictors for metastatic infection,
multivariate analysis was undertaken using logistic re-
gression to adjust for the presence of confounding vari-
ables. Age, sex and all potential predictors with p ≦ 0.1
on univariate analysis were considered for inclusion in
the multivariate model. All statistical analyses were per-
formed with SPSS version 17.0 for Windows.
Results
Comparison of clinical characteristics of KPLA in diabetic
patients with controlled or uncontrolled glycemia
During the study period, 108 diabetic patients from all
of the 221 KPLA cases were identified. We excluded
six patients due to lack of HbA1c. The remaining 102
patients all had type 2 diabetes. HbA1c level < 7% is gen-
erally considered as the target of glycemic control for
diabetic patients [25,26]. We compared patients with
controlled glycemia (HbA1c < 7%) and uncontrolled gly-
cemia (HbA1c ≥ 7%). The level of HbA1c in the group
with uncontrolled glycemia was significantly higher than
that in the group with controlled glycemia (10.0 ± 2.1 vs
6.5 ± 0.3%, p < 0.001).
Table 1 showed the clinical features between these two
groups. Patients with uncontrolled glycemia were youn-
ger (62.8 ± 14.9 vs 70.6 ± 9.6 years, p = 0.017) than those
with controlled glycemia. Patients with poor glycemic
control had the trend to have a higher rate of cryptogenic
Lin et al. BMC Infectious Diseases 2013, 13:56 Page 2 of 7
http://www.biomedcentral.com/1471-2334/13/56
liver abscess (92.8 vs 78. 9%, p = 0.087), gas-forming
liver abscess (14.5 vs 0%, p = 0.116), and metastatic
infection (14.5 vs 0%, p = 0.116) than those with con-
trolled glycemia. The underlying disease did not dif-
fer between the two groups. Most of the lesions were
located in the right lobe, but the characteristics of
abscess did not differ significantly between the two
groups. No mortality was identified in the group with
controlled glycemia. The treatment strategy did not
differ among the groups with different HbA1c levels.
Table 1 Baseline characteristics, clinical presentation, and outcome of diabetic patients with controlled or
uncontrolled glycemia
Controlled
glycemia (n = 19)
Uncontrolled
glycemia (n = 83)
p value p value,
(adjusted age)
Male 12 (63.2) 59 (71.1) 0.498 0.952
Age in years 70.6 ± 9.6 62.8 ± 14.9 0.017
Underlying diseases
Malignancy 1 (5.6) 10 (12.7) 0.683 0.367
Alcoholism 1 (5.3) 4 (4.8) 1.000 0.655
Chronic kidney disease 1 (5.6) 8 (10.3) 1.000 0.311
Liver cirrhosis 0 (0) 2 (2.4) 1.000 0.494
Congestive heart failure 0 (0) 2 (2.4) 1.000 0.392
Chronic lung disease 0 (0) 1 (1.2) 1.000 0.549
Newly diagnosed diabetes 4 (21.1) 21 (25.3) 1.000 0.995
Origin
Cryptogenic 15 (78.9) 77 (92.8) 0.087 0.090
Biliary tract origin 1 (5.3) 5 (6.0) 1.000 0.785
Abscess locations
Right lobe 11 (57.9) 44 (53.0) 0.791 0.407
Left lobe 5 (26.3) 19 (22.9)
Both lobes 3 (15.8) 20 (24.1)
Abscess size
< 5 cm 9 (47.4) 36 (43.4) 1.000 0.707
5 ~ 10 cm 9 (47.4) 39 (47.0)
> 10 cm 1 (5.3) 8 (9.6)
Gas forming 0 (0) 12 (14.5) 0.116 0.126
Multiple abscesses 8 (42.1) 29 (34.9) 0.558 0.791
Initial laboratory value
Leukocyte count, × 103/μL 12.4 ± 3.8 13.5 ± 6.0 0.165 0.417
Platelet, × 103/μL 195 ± 87 229 ± 121 0.145 0.442
C-reactive protein, mg/dL 18.8 ± 9.2 20.0 ± 9.8 0.487 0.779
Glucose, mg/dL 193 ± 76 318 ± 168 0.007 0.004
Treatment
Antibiotics + drainage 16 (84.2) 69 (83.1) 1.000 0.894
Antibiotics + operation 1 (5.3) 3 (3.6) 0.568 0.525
Antibiotics only 2 (10.5) 11 (13.4) 1.000 0.557
Metastatic infections 0 (0) 12 (14.5) 0.116 0.077
Outcome
Hospitalization days 26.2 ± 12.1 28.1 ± 19.0 0.692 0.428
Intensive care unit admission 2 (10.5) 12 (14.5) 1.000 0.849
Mortality 0 (0) 3 (3.6) 1.000 0.359
Data are presented as mean ± SD or frequency with percentage (%).
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Length of stay in hospital and intensive care unit admis-
sion rate did not differ significantly between the two
groups. As the age is significantly different between the
groups, we compared all the characteristics after ad-
justment with age, which showed the consistent results.
Only 41 isolates of K. pneumonaie were available for
microbiological analysis, and we found that 21 isolates
were positive for magA. The distribution of magA in K.
pneumoniae isolates did not differ between controlled
and uncontrolled groups (66.7% vs 46.9%, p = 0.454).
Table 2 Baseline characteristics, clinical presentation, and outcome of diabetic patients with KPLA according to
different HbA1c levels
Factor HbA1c < 7% (n = 19) HbA1c = 7 ~ 10% (n = 44) HbA1c > 10% (n = 39) p value p value, (adjusted age)
Male 12 (63.2) 30 (68.2) 29 (74.4) 0.660 0.999
Age in years 71.3 ± 9.9 68.2 ± 11.4 56.3 ±15.8 <0.001
Underlying diseases
Malignancy 1 (5.6) 8 (20.0) 2 (5.1) 0.100 0.560
Alcoholism 1 (5.3) 0 (0) 4 (10.3) 0.081 0.378
Chronic kidney disease 1 (5.6) 7 (17.5) 1 (2.6) 0.067 0.889
Liver cirrhosis 0 (0) 2 (4.5) 0 (0) 0.667 0.676
Congestive heart failure 0 (0) 2 (4.5) 0 (0) 0.667 0.970
Chronic lung disease 0 (0) 1 (2.3) 0 (0) 1.000 0.979
Newly diagnosed diabetes 4 (21.1) 6 (13.6) 15 (38.5) 0.028 0.146
Origin
Cryptogenic 15 (78.9) 38 (86.4) 39 (100.0) 0.008 0.008
Biliary tract origin 1 (5.3) 5 (11.4) 0 (0) 0.068 0.287
Abscess locations
Right lobe 11 (57.9) 23 (52.3) 21 (53.8) 0.442 0.214
Left lobe 5 (26.3) 13 (29.5) 6 (15.4)
Both lobes 3 (15.8) 8 (18.2) 12 (30.8)
Abscess size
< 5 cm 9 (47.4) 18 (40.9) 18 (46.2) 0.962 0.829
5 ~ 10 cm 9 (47.4) 21 (47.7) 18 (46.2)
> 10 cm 1 (5.3) 5 (11.4) 3 (7.7)
Gas forming 0 (0) 6 (13.6) 6 (15.4) 0.218 0.317
Multiple abscesses 8 (42.1) 12 (27.3) 17 (43.6) 0.256 0.308
Initial laboratory value
Leukocyte count, × 103/μL 12.4 ± 3.8 14.4 ± 5.6 12.4 ± 6.2 0.168 0.225
Platelet, × 103/μL 195 ± 87 222 ± 102 237 ± 140 0.380 0.734
C-reactive protein, mg/dL 18.8 ± 9.2 19.3 ± 9.6 20.9 ± 10.1 0.539 0.826
Glucose, mg/dL 193 ± 76 270 ± 152 371 ± 170 <0.001 <0.001
Treatment
Antibiotics + drainage 16 (84.2) 37 (84.1) 32 (82.1) 1.000 0.779
Antibiotics + operation 1 (5.3) 2 (4.5) 1 (2.6) 1.000 0.345
Antibiotics only 2 (10.5) 6 (13.6) 5 (13.2) 1.000 0.524
Metastatic infections, 0 (0) 3 (6.8) 9 (23.1) 0.021 0.004
Outcome
Hospitalization days 26.3 ± 15.7 31.9 ± 23.2 24.9 ± 12.5 0.201 0.265
ICU admission 2 (10.5) 5 (11.4) 7 (17.9) 0.695 0.605
Mortality 0 (0) 1 (2.3) 2 (5.1) 0.785 0.181
Data are presented as mean ± SD or frequency with percentage (%).
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Comparison of clinical characteristics in KPLA diabetic
patients according to different HbA1c levels
To analyze further the impact of glycemic control on the
clinical characteristics of KPLA, we divided the patients
into three groups according to HbA1c level: < 7%, 7–10%
and > 10%, as shown in Table 2. A HbA1c level > 10%
suggested poorly controlled diabetes [25]. The level of
HbA1c was significantly different in the three groups
(6.5 ± 0.3 vs 8.4 ± 0.9 vs 11.8 ± 1.6%, p < 0.001). Patients
with HbA1c > 10% were significantly younger (p < 0.001)
than the other two groups. Newly diagnosed diabetes,
cryptogenic origin abscess, and metastatic infection were
more common in the group of HbA1c level > 10%. Crypto-
genic origin abscess and metastatic infection were still
more common in the group of HbA1c level > 10% after ad-
justment with age.
Risk factors for metastatic infections from KPLA in
diabetic patients
The rate of metastatic infection was 11.8% in diabetic
KPLA (n = 12), and the commonest infectious site was
the eyes (n = 3) and lungs (n = 3), followed by the spleen
(n = 2), kidneys (n = 2), prostate (n = 1), and muscle over
the left thigh (n = 1). Two patients with metastatic
infection died and the mortality rate was significantly
higher than that without metastatic infection (16.7 vs
1.1%, p = 0.036). Table 3 showed the risk factors meta-
static infection from KPLA. Logistic regression analysis
revealed that HbA1c level (odds ratio [OR], 1.50; 95%
confidence interval [CI], 1.01-2.25; p = 0.047) abscess
size < 5 cm (OR, 4.72; 95% CI, 1.09–20.52; p = 0.038)
were the independent predictors of metastatic infection.
Discussion
It is believed that several aspects of immunity are altered
in patients with diabetes. For example, polymorpho-
nuclear leukocyte function is depressed; leukocyte adher-
ence, chemotaxis and phagocytosis may be affected; and
antioxidant systems involved in bactericidal activity may
also be impaired. Although these in vitro findings have
not yet been fully confirmed in clinical studies, there is
evidence that improving glycemic control in patients
improves immune function [27]. Kornum et al. found
that an elevated HbA1c predicted increased risk for all-
cause community-acquired pneumonia among patients
with diabetes [28]. In diabetic patients with sepsis, one
study has demonstrated that HbA1c is an independent
prognostic factor for hospital mortality and length of
Table 3 Risk factors for metastatic infection of KPLA in diabetic patients
No metastatic
infection (n = 90)
Metastatic
infection (n = 12)
Univariate analysis Multivariate analysis
Factor p value Odds Ratio (95% CI) p value
Male 63 (70.0) 8 (66.7) 0.814 0.76 (0.16–3.59) 0.733
Age in years 64.4 ± 14.2 63.2 ± 16.0 0.779 1.02 (0.97–1.08) 0.430
Underlying diseases
Malignancy 10 (11.8) 1 (8.3) 0.772 – –
Alcoholism 4 (4.8) 1 (8.3) 0.564 – –
Chronic kidney disease 9 (10.6) 0 (0) 0.999 – –
Liver cirrhosis 2 (2.2) 0 (0) 0.999 – –
Congestive heart failure 2 (2.2) 0 (0) 0.999 – –
Chronic lung disease 1 (1.1) 0 (0) 1.000 – –
Newly diagnosed diabetes 21 (23.3) 4 (33.3) 0.453 – –
HbA1c 9.1 ± 2.3 11.0 ± 2.3 0.015 1.50 (1.01–2.25) 0.047
Cryptogenic origin 80 (88.9) 12 (100) 0.999 – –
Abscess locations in both lobes 18 (20.0) 5 (41.7) 0.102 1.48 (0.29–7.60) 0.646
Abscess size < 5 cm 36 (40) 9 (75) 0.032 4.72 (1.09–20.52) 0.038
Gas forming 11 (12.2) 1 (8.3) 0.693 – –
Multiple abscesses 29 (32.2) 8 (66.7) 0.028 3.03 (0.62–14.74) 0.170
Initial laboratory value
Leucocyte count, × 103/μL 13.2 ± 5.5 13.9 ± 6.8 0.653 – –
Platelet, × 103/μL 225 ± 117 209 ± 113 0.654 – –
C-reactive protein, mg/dL 19.5 ± 9.6 22.3 ± 9.6 0.339 – –
Glucose, mg/dL 284 ± 150 380 ± 229 0.071 1.00 (0.99–1.00) 0.728
Data are presented as mean ± SD or frequency with percentage (%).
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stay [29]. Regarding the issue of glycemic control and
KPLA, only one case series from Taiwan analyzing 6
cases of recurrent KPLA has been reported in the lite-
rature. Five of the six patients had diabetes with poor
glycemic control, and four had HbA1c > 9% (range:
9.2–17.5%) [30]. The current study is, to the best of our
knowledge, the first to investigate the effect of glycemic
control on characteristics of KPLA in diabetic patients.
In our study, we found that patients with uncontrolled
glycemia tended to be younger, and had the trend to have
a higher rate of cryptogenic liver abscess, gas-forming liver
abscess, and metastatic infection than those with con-
trolled glycemia, although these differences did not reach
significance. Young age, newly diagnosed diabetes, crypto-
genic liver abscess and metastatic infection were more
common in the poor glycemic control group (HbA1c val-
ue > 10%). Cryptogenic invasive KPLA is frequently asso-
ciated with diabetes [23]; therefore, we further established
that it was highly linked to diabetic patients with high
level of HbA1c. The finding that younger patients with
KPLA are prone to have uncontrolled glycemia has never
been reported, in part due to the small sample sizes of
studies reported in the literature [6,13].
Lin et al. have analyzed the effect of glycemic control
of type 2 diabetes on neutrophil phagocytosis of serotype
K1/K2 K. pneumoniae isolates. This in vitro study sug-
gests that strict metabolic control may improve the neu-
trophil phagocytosis of K1/K2 K. pneumoniae in patients
with type 2 diabetes [31]. In the current study focusing
on diabetic patients, we not only found that the rate of
metastatic infection was more common in patients with
poor glycemic control, but also that HbA1c level was an
independent risk factor for metastatic infection. It is also
notable that there was no mortality, metastatic infection
or gas-forming abscess in the group with controlled gly-
cemia. The previous in vitro study by Lin et al. may sup-
port our clinical findings, and we suggest that HbA1c
level is detrimental in KPLA, and controlled glycemia
may prevent the development of serious metastatic
complications.
Previous case reports have demonstrated that diag-
nosis of diabetes may come to light because of KPLA
[32,33]. It is notable that around 25% of cases were
newly recognized diabetes in the current study despite
improvement in diagnosis and awareness in recent years,
and the existence of a comprehensive national health in-
surance program in Taiwan that optimizes access to
medical care. Due to unrecognized diabetes complicated
with infection, extreme hyperglycemia, even hypergly-
cemic hyperosmolar state or diabetic ketoacidosis, may
occur. Physicians should not ignore the underlying dia-
betes in patients with KPLA in clinical practice. One
particularly interesting finding in our study was that liver
abscess < 5 cm in diabetic patients was independently
associated with metastatic infection, which has not been
reported in the literature. It suggested that we should not
overlook the risk of complication from small sized liver
abscess in diabetic patients.
We acknowledge some limitations in our study that
deserve mention. First, the data were collected retrospec-
tively from medical records. Second, participants were
recruited from a medical center in Northern Taiwan, and
therefore we could not evaluate possible regional varia-
tions. Further analyses should be conducted in other re-
gions and countries to confirm our findings. Thirdly, our
results were also limited by the incomplete collection of
HbA1c data. Finally, the isolates were not collected for fur-
ther analysis, such as virulence factors or clonal types, in
the current study. Despite these limitations, our study is
believed to be the first to discuss the characteristics of
KPLA due to the different level of glycemic control, which
sheds further light on the association between diabetes
and KPLA, and our results may partly elucidate the role
of host factors in the pathogenesis of KPLA.
Conclusion
Patients with uncontrolled glycemia were significantly
younger than those with controlled glycemia. Patients
with uncontrolled glycemia had the trend to have a
higher rate of gas-forming liver abscess, cryptogenic liver
abscess and metastatic infection than those with con-
trolled glycemia. Cryptogenic liver abscess and meta-
static infection were more common in the poor glycemic
control group (HbA1c value > 10%). HbA1c level and ab-
scess < 5 cm were independent risk factors for metasta-
tic complications from KPLA. Therefore, glycemic control
in diabetic patients plays an essential role in the clinical
features of KPLA, especially in metastatic complications
from KPLA.
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